{
    "nctId": "NCT02610439",
    "briefTitle": "Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer",
    "officialTitle": "Exploratory Next Generation Sequencing to Identify Causative Variants for Taxane-Induced Peripheral Neuropathy From Breast Cancer Study E5103 Germline DNA Samples",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma, Neuropathy",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 575,
    "primaryOutcomeMeasure": "Identification of rare coding variants of large effect that predict the risk of peripheral neuropathy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* European American patients with DNA available and designated case or control\n* African American patients with DNA available and designated case or control status\n* Patients who developed grade 2-4 for African American (AA) and grade 3-4 for European American (EA) peripheral neuropathy during their treatment with paclitaxel and who did not develop peripheral neuropathy following a full course of treatment with paclitaxel",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}